R&D capitalization changes are reshaping trial funding. The real impact hits clinical supply, where tax strategy now directly influences timelines, inventory, and execution.
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
- Designing Clinical Trials For Hard-To-Access Patients
- How Clinical Supply Teams Can Prevent Cross-Border Shipping Delays
- AI In Clinical Supply – Hype, Hope, And The Path To Predictive Precision
ON-DEMAND WEBINARS
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Gain a deeper understanding of current directives and metrics to equip your team with the knowledge necessary to navigate the evolving landscape of sustainability.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages- 1317948272 drug delivery]( "RTSM Manages Clinical IP Dispensation In Schizophrenia Study")
RTSM Manages Clinical IP Dispensation In Schizophrenia StudyChallenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
![GettyImages-1316775813-vial-production]( "Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C")
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°CThis study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
![stress frustrate doctor iStock-1040929824]( "My Worst Nightmare In RSTM: Accidental Unblinding")
My Worst Nightmare In RSTM: Accidental UnblindingLearn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.
-
![GettyImages-1333159166-cold-chain-shipping-logistics-transportation]( "Overcoming Obstacles To Deliver Critical Autologous Cell Therapy")
Overcoming Obstacles To Deliver Critical Autologous Cell TherapySee how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany
-
![GettyImages-944060504 coworkers computer]( "Top 5 Dos And Don'ts Of RTSM")
Top 5 Dos And Don'ts Of RTSMDiscover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
![GettyImages-1288118586 cell development]( "Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials")
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical TrialsLearn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
![GettyImages-1413600685-scientists-collaborate]( "Creating A Sustainable Pharmaceutical Supply Chain")
Creating A Sustainable Pharmaceutical Supply ChainLearn how CDMOs can drive transformation in the supply chain and create a more sustainable future for the pharmaceutical manufacturing industry.
-
![GettyImages-1266357505-vaccine-development-lab]( "How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs")
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial NeedsWhen selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
![iStock-486571129-supply-chain-logistics-packaging]( "Is Your Clinical Supply Strategy Ready For EU CTR?")
Is Your Clinical Supply Strategy Ready For EU CTR?One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
![cdmo-drug-assembly-manual-GettyImages-1339603591]( "Practical Playbook For The Manual Assembly Of Combination Products")
Practical Playbook For The Manual Assembly Of Combination ProductsManual assembly plays a vital role in early‑phase combination product development. Learn how strong process design, collaboration, and quality controls help teams reduce risk, improve consistency, and move confidently toward later‑stage manufacturing.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
